Filing Flows

Filing Flows › CME Group (CME) › Q3 2026

CME Group (CME) Q3 2026 earnings results (third quarter 2026)

10-Q filed Oct 23, 2026

CME Group (CME) reported revenue of $1.7B for the third quarter 2026 (Q3 2026), +13% from a year earlier and +2% from the quarter before. Operating margin was 65.7%, net earnings $1.0B (59.7% of revenue).

Revenue$1.7B
Year over year+13%
Quarter over quarter+2%
Operating margin65.7%
Net earnings$1.0B

CME Group, Q3 2026: revenue $1.7B (+13% year over year), operating margin 65.7%, net earnings $1.0B, operating cash flow $1.1B. The chart follows the revenue to costs, profit and cash.

Q3 2026AmountQ/QY/Y
Revenue$1.7B+2%+13%
Operating profit$1.1B+3%+17%
Net earnings$1.0B-0.5%+14%
Operating cash flow$1.1B+15%+12%
Free cash flow$1.1B+16%+13%

What changed

Revenue was $1.7B in Q3 2026, up 13% year over year and up 2% from the previous quarter. Clearing and transaction fees was the largest line at 79% of revenue. Clearing and transaction fees added $0.15B year over year (up 12%), 75% of the total change.

Operating profit was $1.1B, a 65.7% margin (up 2.4 points year over year). Of the extra revenue versus Q3 2025, 85% reached operating profit, above the 63% margin then. Total costs grew 5% against revenue growth of 13%. Net earnings were $1.0B, up 14% year over year. The effective tax rate was 23.5%.

Operating cash flow was $1.1B (up 12% year over year), 105% of net earnings. Non-cash charges added back $0.08B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.06B. Capital expenditures of $0.02B left free cash flow of $1.1B.

Questions

What was CME Group's revenue in the third quarter 2026?

CME Group (CME) reported revenue of $1.7B for the third quarter 2026 (Q3 2026), +13% from a year earlier and +2% from the quarter before.

Was CME Group profitable in the third quarter 2026?

Operating profit was $1.1B (65.7% of revenue) and net earnings $1.0B.

Open the interactive Sankey →

Source: CME Group 10-Q on SEC EDGAR.